<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of microbiology, epidemiology and immunobiology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of microbiology, epidemiology and immunobiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Журнал микробиологии, эпидемиологии и иммунобиологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0372-9311</issn><issn publication-format="electronic">2686-7613</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">7271</article-id><article-id pub-id-type="doi">10.36233/0372-9311-386</article-id><article-id pub-id-type="edn">rpsjli</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Type 4 secretion system in Clostridioides difficile: Structural features and its role as a pathogenicity factor</article-title><trans-title-group xml:lang="ru"><trans-title>Система секреции 4-го типа у Clostridioides difficile: структурные особенности и её роль как фактора патогенности</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1869-742X</contrib-id><name-alternatives><name xml:lang="en"><surname>Sorokina</surname><given-names>Julya V.</given-names></name><name xml:lang="ru"><surname>Сорокина</surname><given-names>Юлия Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Researcher, Department of Bacterial Infections</p></bio><bio xml:lang="ru"><p>н.с. отдела бактериальных инфекций</p></bio><email>YV_Sorokina@gamaleya.org</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2312-1465</contrib-id><name-alternatives><name xml:lang="en"><surname>Belyi</surname><given-names>Yuriy  F.</given-names></name><name xml:lang="ru"><surname>Белый</surname><given-names>Юрий Фёдорович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Head, Department of Bacterial Infections</p></bio><bio xml:lang="ru"><p>д.м.н., рук. отдела бактериальных инфекций</p></bio><email>belyi@gamaleya.org</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Gamaleya Research Centre for Epidemiology and Microbiology</institution></aff><aff><institution xml:lang="ru">Национальный исследовательский центр эпидемиологии и микробиологии имени Н.Ф. Гамалеи</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-09-21" publication-format="electronic"><day>21</day><month>09</month><year>2023</year></pub-date><volume>100</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>345</fpage><lpage>353</lpage><history><date date-type="received" iso-8601-date="2023-03-28"><day>28</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Sorokina J.V., Belyi Y.F.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Сорокина Ю.В., Белый Ю.Ф.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Sorokina J.V., Belyi Y.F.</copyright-holder><copyright-holder xml:lang="ru">Сорокина Ю.В., Белый Ю.Ф.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://microbiol.crie.ru/jour/article/view/7271">https://microbiol.crie.ru/jour/article/view/7271</self-uri><abstract xml:lang="en"><p><italic>Clostridioides difficile </italic>is a gram-positive microorganism causing damage to the human intestinal wall, clinically manifesting as antibiotic-associated diarrhea and pseudomembranous colitis. <italic>C</italic><italic>. </italic><italic>difficile</italic> infection remains a serious problem; the increasing frequency of nosocomial outbreaks and the emergence of community-acquired forms heighten the need for new prevention and treatment methods. The pathogenesis of <italic>C</italic><italic>. </italic><italic>difficile</italic> infection is associated with the toxins produced by bacteria and a large group of proteins promoting the replication of the pathogen in host tissues and its spread in the human population. Recent studies show that mobile genetic elements play a key role in the high virulence of <italic>C. difficile</italic>. Type 4 secretion systems (T4SS) are significant components of these elements; their impressive diversity among gram-positive microorganisms in general and in <italic>C. difficile,</italic> in particular, implies their high evolutionary and, consequently, medical significance. Further studies of the T4SS composition and structure will provide a deeper insight into mechanisms underlying the development of respective infections and will help outline pathogenically grounded approaches to prevention and treatment of diseases caused by<italic> C. difficile</italic>. On the other hand, the key components of the secretion machinery of the pathogen can be used in bioinformatic analysis and for searching new adaptive clusters in the genome of highly virulent strains.</p></abstract><trans-abstract xml:lang="ru"><p><italic>Clostridioides</italic> <italic>difficile</italic> <italic>— </italic>грамположительный микроорганизм, вызывающий поражения стенки кишечника человека, которые проявляются клинически в виде антибиотикоассоциированной диареи и псевдомембранозного колита. Проблема инфекции <italic>C</italic><italic>. </italic><italic>difficile</italic> не теряет актуальности, а с распространением внутрибольничных вспышек и появлением внебольничных форм растёт потребность в новых видах её профилактики и лечения. Патогенез инфекции <italic>C</italic><italic>. </italic><italic>difficile</italic> связан с продукцией бактериями токсинов и большой группы иных белков, благоприятствующих размножению патогена в тканях макроорганизмов и его распространению в популяции людей. Исходя из исследований последних лет можно заключить, что высокой вирулентности <italic>C</italic><italic>. </italic><italic>difficile</italic> способствуют мобильные генетические элементы. Важнейшими компонентами этих элементов являются системы секреции 4-го типа (СС4Т), впечатляющее разнообразие которых среди грамположительных микроорганизмов вообще и <italic>C</italic><italic>. </italic><italic>difficile</italic> в частности говорит об их высокой эволюционной и, следовательно, медицинской значимости. Дальнейшее изучение состава и строения СС4Т позволит расширить понимание механизмов развития соответствующих инфекций и наметить патогенетически обоснованные подходы к профилактике и лечению заболеваний, вызываемых <italic>C</italic><italic>. </italic><italic>difficile</italic>. С другой стороны, ключевые компоненты секреторного аппарата патогена могут быть использованы для биоинформационного анализа и поиска новых адаптивных кластеров в геноме высоковирулентных штаммов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>type 4 secretion system</kwd><kwd>pathogenicity factors</kwd><kwd>Clostridioides difficile</kwd><kwd>conjugative transposons</kwd><kwd>antibiotic-resistant strains</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>система секреции 4-го типа</kwd><kwd>факторы патогенности</kwd><kwd>Clostridioides difficile</kwd><kwd>конъюгативные транспозоны</kwd><kwd>антибиотикоустойчивые штаммы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hall I.C., O'Toole E. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am. J. Dis. Child. 1935;49(2):390. DOI: https://doi.org/10.1001/archpedi.1935.01970020105010</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Riley T.V., Wymer V., Bamford V.W., Bowman R.A. Clostridium difficile in general practice and community health. J. Hyg. (Lond.). 1986;96(1):13–7. DOI: https://doi.org/10.1017/s0022172400062483</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Guh A.Y., Mu Y., Winston L.G., et al. Trends in U.S. Burden of Clostridioides difficile infection and outcomes. N. Engl. J. Med. 2020;382(14):1320–30. DOI: https://doi.org/10.1056/nejmoa1910215</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Lyerly D.M., Saum K.E., MacDonald D.K., Wilkins T.D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 1985;47(2):349–52. DOI: https://doi.org/10.1128/iai.47.2.349-352.1985</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Orrell K.E., Melnyk R.A. Large clostridial toxins: mechanisms and roles in disease. Microbiol. Mol. Biol. Rev. 2021;85(3):e0006421. DOI: https://doi.org/10.1128/mmbr.00064-21</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Popoff M.R., Rubin E.J., Gill D.M., Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect. Immun. 1988;56(9):2299–306. DOI: https://doi.org/10.1128/iai.56.9.2299-2306.1988</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Aktories K., Papatheodorou P., Schwan C. Binary Clostridium difficile toxin (CDT) — a virulence factor disturbing the cytoskeleton. Anaerobe. 2018;53:21–9. DOI: https://doi.org/10.1016/j.anaerobe.2018.03.001</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Riedel T., Neumann-Schaal M., Wittmann J., et al. Characterization of Clostridioides difficile DSM 101085 with A–B–CDT + phenotype from a late recurrent colonization. Genome Biol. Evol. 2020;12(5):566–77. DOI: https://doi.org/10.1093/gbe/evaa072</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Merrigan M.M., Venugopal A., Roxas J.L., et al. Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficile. PLoS One. 2013;8(11):e78404. DOI: https://doi.org/10.1371/journal.pone.0078404</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Shen A. Clostridioides difficile spore formation and germination: new insights and opportunities for intervention. Annu. Rev. Microbiol. 2020;74(1):545–66. DOI: https://doi.org/10.1146/annurev-micro-011320-011321</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Taggart M.G., Snelling W.J., Naughton P.J., et al. Biofilm regulation in Clostridioides difficile: novel systems linked to hypervirulence. PLOS Pathog. 2021;17(9):e1009817. DOI: https://doi.org/10.1371/journal.ppat.1009817</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>de la Riva L., Willing S.E., Tate E.W., Fairweather N.F. Roles of cysteine proteases Cwp84 and Cwp13 in biogenesis of the cell wall of Clostridium difficile. J. Bacteriol. 2011;193(13):3276–85. DOI: https://doi.org/10.1128/jb.00248-11</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Coullon H., Candela T. Clostridioides difficile peptidoglycan modifications. Curr. Opin. Microbiol. 2022;65:156–61. DOI: https://doi.org/10.1016/j.mib.2021.11.010</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>McKee R.W., Harvest C.K., Tamayo R. Cyclic diguanylate regulates virulence factor genes via multiple riboswitches in Clostridium difficile. mSphere. 2018;3(5):e00423-18. DOI: https://doi.org/10.1128/msphere.00423-18</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Buddle J.E., Fagan R.P. Pathogenicity and virulence of Clostridioides difficile. Virulence. 2023;14(1):2150452. DOI: https://doi.org/10.1080/21505594.2022.2150452</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Androga G.O., Knight D.R., Hutton M.L., et al. In silico, in vitro and in vivo analysis of putative virulence factors identified in large clostridial toxin-negative, binary toxin-producing C. difficile strains. Anaerobe. 2019;60:102083. DOI: https://doi.org/10.1016/j.anaerobe.2019.102083</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lee A.S.Y., Song K.P. LuxS/autoinducer-2 quorum sensing molecule regulates transcriptional virulence gene expression in Clostridium difficile. Biochem. Biophys. Res. Commun. 2005;335(3):659–66. DOI: https://doi.org/10.1016/j.bbrc.2005.07.131</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Okada Y., Okugawa S., Ikeda M., et al. Genetic diversity and epidemiology of accessory gene regulator loci in Clostridioides difficile. Access Microbiol. 2020;2(7):acmi.0.000134. DOI: https://doi.org/10.1099/acmi.0.000134</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Ahmed U.K.B., Shadid T.M., Larabee J.L., Ballard J.D. Combined and distinct roles of Agr proteins in Clostridioides difficile 630 sporulation, motility, and toxin production. mBio. 2020;11(6):e03190-20. DOI: https://doi.org/10.1128/mbio.03190-20</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Aguilar-Zamora E., Weimer B.C., et al. Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in hospitalized patients from Mexico. Front. Microbiol. 2022;12:787451. DOI: https://doi.org/10.3389/fmicb.2021.787451</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Wen X., Shen C., Xia J., et al. Whole-genome sequencing reveals the high nosocomial transmission and antimicrobial resistance of Clostridioides difficile in a single center in China, a four-year retrospective study. 2021;10(1):e01322-21. DOI: https://doi.org/10.1128/spectrum.01322-21</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Darkoh C., Keita K., Odo C., et al. Emergence of clinical Clostridioides difficile isolates with decreased susceptibility to vancomycin. Clin. Infect. Dis. 2022;74(1):120–6. DOI: https://doi.org/10.1093/cid/ciaa912</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Launay A., Ballard S.A., Johnson P.D., et al. Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. Antimicrob. Agents Chemother. 2006;50(3):1054–62. DOI: https://doi.org/10.1128/aac.50.3.1054-1062.2006</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Zhang W., Cheng Y., Du P., et al. Genomic study of the type IVC secretion system in Clostridium difficile: understanding C. difficile evolution via horizontal gene transfer. Genome. 2017;60(1):8–16. DOI: https://doi.org/10.1139/gen-2016-0053</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Li Y.G., Christie P.J. The agrobacterium VirB/VirD4 T4SS: mechanism and architecture defined through in vivo mutagenesis and chimeric systems. Curr. Top. Microbiol. Immunol. 2018;418:233–60. DOI: https://doi.org/10.1007/82_2018_94</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Böck D., Hüsler D., Steiner B., et al. The polar Legionella Icm/Dot T4SS establishes distinct contact sites with the pathogen vacuole membrane. mBio. 2021;12(5):e0218021. DOI: https://doi.org/10.1128/mbio.02180-21</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Grohmann E., Christie P.J., Waksman G., Backert S. Type IV secretion in gram-negative and gram-positive bacteria: type IV secretion. Mol. Microbiol. 2018;107(4):455–71. DOI: https://doi.org/10.1111/mmi.13896</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Zhao Y., Liu G., Li S., et al. Role of a type IV-like secretion system of Streptococcus suis 2 in the development of streptococcal toxic shock syndrome. J. Infect. Dis. 2011;204(2):274–81. DOI: https://doi.org/10.1093/infdis/jir261</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Zhong Q., Zhao Y., Chen T., et al. A functional peptidoglycan hydrolase characterized from T4SS in 89K pathogenicity island of epidemic Streptococcus suis serotype 2. BMC Microbiol. 2014;14:73. DOI: https://doi.org/10.1186/1471-2180-14-73</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Bhatty M., Cruz M.R., Frank K.L., et al. Enterococcus faecalis pCF10-encoded surface proteins PrgA, PrgB (aggregation substance), and PrgC contribute to plasmid transfer, biofilm formation, and virulence. Mol. Microbiol. 2015;95(4):660–77. DOI: https://doi.org/10.1111/mmi.12893</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Sorokina J., Sokolova I., Rybolovlev I., et al. VirB4- and VirD4-like ATPases, components of a putative type 4C secretion system in Clostridioides difficile. J. Bacteriol. 2021;203(21):e00359-21. DOI: https://doi.org/10.1128/jb.00359-21</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Backert S. Erratum to: Type IV secretion in Gram-negative and Gram-positive bacteria. Curr. Top. Microbiol. Immunol. 2017; 413:E1. DOI: https://doi.org/10.1007/978-3-319-75241-9_14</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Zhang W., Rong C., Chen C., Gao G.F. Type-IVC secretion system: a novel subclass of type IV secretion system (T4SS) common existing in gram-positive genus Streptococcus. PLoS One. 2012;7(10):e46390. DOI: https://doi.org/10.1371/journal.pone.0046390</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Bhatty M., Laverde Gomez J.A., Christie P.J. The expanding bacterial type IV secretion lexicon. Res. Microbiol. 2013;164(6):620–39. DOI: https://doi.org/10.1016/j.resmic.2013.03.012</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Wang J., Feng Y., Wang C., et al. Pathogenic Streptococcus strains employ novel escape strategy to inhibit bacteriostatic effect mediated by mammalian peptidoglycan recognition protein. Cell. Microbiol. 2017;19(7). DOI: https://doi.org/10.1111/cmi.12724</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Das A. Identification of a carboxy-terminal glutamine-rich domain in Agrobacterium tumefaciens coupling protein VirD4 required for recognition of T-Strand DNA and Not VirE2 as a substrate for transfer to plant cells. Mol. Plant Microbe Interact. 2020;33(2):166–72. DOI: https://doi.org/10.1094/mpmi-04-19-0099-r</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Amro J., Black C., Jemouai Z., et al. Cryo-EM structure of the Agrobacterium tumefaciens T-pilus reveals the importance of positive charges in the lumen. Structure. 2023;31(4):375–84.e4. DOI: https://doi.org/10.1016/j.str.2022.11.007</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Roushan M.R., de Zeeuw M.A.M., Hooykaas P.J.J., van Heusden G.P.H. Application of phiLOV2.1 as a fluorescent marker for visualization of Agrobacterium effector protein translocation. Plant J. 2018;96(3):685–99. DOI: https://doi.org/10.1111/tpj.14060</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Чумаков М.И., Мазилов С.И., Гусев Ю.С., Волохина И.В. Исследование способности агробактериального белка VirE2 к образованию пор в мембранах. Биологические мембраны. 2010;27(5):449–54. Chumakov M.I., Mazilov S.I., Gusev Yu.S., Volokhina I.V. Study of the ability of agrobacterial protein VirE2 to form pores in membranes. Biological Membranes. 2010;27(5):449–54. EDN: https://www.elibrary.ru/mvskun</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Дюбо Ю.В., Николайчик Е.А. Модификация вирулентных свойств Pectobacterium atrosepticum конъюгативной плазмидой pPA21A. Молекулярная и прикладная генетика. 2018;24:37–44. Dyubo Yu.V., Nikolaichik E.A. Modification virulent properties of Pectobacterium atrosepticum by conjugative plasmid PPA21A. Molecular and Applied Genetics. 2018;24:37–44. EDN: https://www.elibrary.ru/hgoxko</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Pfannkuch L., Hurwitz R., Traulsen J., et al. ADP heptose, a novel pathogen‐associated molecular pattern identified in Helicobacter pylori. FASEB J. 2019;33(8):9087–99. DOI: https://doi.org/10.1096/fj.201802555r</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Zhang X., Li C., Chen D., et al. H. pylori CagA activates the NLRP3 inflammasome to promote gastric cancer cell migration and invasion. Inflamm. Res. 2022;71(1):141–55. DOI: https://doi.org/10.1007/s00011-021-01522-6</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Allombert J., Jaboulay C., Michard C., et al. Deciphering Legionella effector delivery by Icm/Dot secretion system reveals a new role for c-di-GMP signaling. J. Mol. Biol. 2021;433(13):166985. DOI: https://doi.org/10.1016/j.jmb.2021.166985</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Beare P.A., Gilk S.D., Larson C.L., et al. Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages. mBio. 2011;2(4):e00175-11. DOI: https://doi.org/10.1128/mbio.00175-11</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Clemente T.M., Augusto L., Angara R.K., Gilk S.D. Coxiella burnetii actively blocks IL-17-induced oxidative stress in macrophages. bioRxiv. 2023;2023.03.15.532774. Preprint. DOI: https://doi.org/10.1101/2023.03.15.532774</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Luo J., Wang L., Song L., Luo Z.Q. Exploitation of the host ubiquitin system: means by Legionella pneumophila. Front. Microbiol. 2021;12:790442. DOI: https://doi.org/10.3389/fmicb.2021.790442</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Тартаковская Д.И. Эукариотические мишени цитотоксической глюкозилтрансферазы Legionella pneumophila. Инфекция и иммунитет. 2012;2(1-2):325. Tartakovskaya D.I. Eukaryotic targets of cytotoxic glucosyltransferase Legionella pneumophila. Russian Journal of Infection and Immunity. 2012;2(1-2):325.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Levanova N., Steinemann M., Böhmer K.E., Schneider S., et al. Characterization of the glucosyltransferase activity of Legionella pneumophila effector SetA. Naunyn Schmiedebergs Arch. Pharmacol. 2019;392(1):69–79. DOI: https://doi.org/10.1007/s00210-018-1562-9</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Liu L., Roy C.R. The Legionella pneumophila effector RavY contributes to a replication-permissive vacuolar environment during infection. Infect. Immun. 2021;89(12):e0026121. DOI: https://doi.org/10.1128/iai.00261-21</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Kurenbach B., Bohn C., Prabhu J., et al. Intergeneric transfer of the Enterococcus faecalis plasmid pIP501 to Escherichia coli and Streptomyces lividans and sequence analysis of its tra region. Plasmid. 2003;50(1):86–93. DOI: https://doi.org/10.1016/s0147-619x(03)00044-1</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Abajy M.Y., Kopeć J., Schiwon K., et al. A type IV-secretion-like system is required for conjugative DNA transport of broad-host-range plasmid pIP501 in Gram-positive bacteria. J. Bacteriol. 2007;189(6):2487–96. DOI: https://doi.org/10.1128/jb.01491-06</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Kohler V., Vaishampayan A., Grohmann E. Broad-host-range Inc18 plasmids: occurrence, spread and transfer mechanisms. Plasmid. 2018;99:11–21. DOI: https://doi.org/10.1016/j.plasmid.2018.06.001</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Durie C.L., Sheedlo M.J., Chung J.M., et al. Structural analysis of the Legionella pneumophila Dot/Icm type IV secretion system core complex. eLife. 2020;9:e59530. DOI: https://doi.org/10.7554/elife.59530</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Revitt-Mills S.A., Watts T.D., Lyras D., et al. The ever-expanding tcp conjugation locus of pCW3 from Clostridium perfringens. Plasmid. 2021;113:102516. DOI: https://doi.org/10.1016/j.plasmid.2020.102516</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Tang J., Wang C., Feng Y., et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med. 2006; 3(5):e151. DOI: https://doi.org/10.1371/journal.pmed.0030151</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Li M., Wang C., Feng Y., et al. SalK/SalR, a two-component signal transduction system, is essential for full virulence of highly invasive Streptococcus suis serotype 2. PLoS One. 2008;3(5):e2080. DOI: https://doi.org/10.1371/journal.pone.0002080</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Li M., Shen X., Yan J., et al. GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2: T4SS-mediated transfer of 89K PAI in S. suis 2. Mol. Microbiol. 2011;79(6):1670–83. DOI: https://doi.org/10.1111/j.1365-2958.2011.07553.x</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Li N., Jia H., Yang H., et al. Preliminary screening of type IV secretion system in divergent geographic sources of Clostridium difficile. Exp. Ther. Med. 2017;14(5):4405–10. DOI: https://doi.org/10.3892/etm.2017.5065</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Whitaker N., Berry T.M., Rosenthal N., et al. Chimeric coupling proteins mediate transfer of heterologous type IV effectors through the Escherichia coli pKM101-encoded conjugation machine. J. Bacteriol. 2016;198(19):2701–18. DOI: https://doi.org/10.1128/jb.00378-16</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Fernández-López R., Garcillán-Barcia M.P., Revilla C., et al. Dynamics of the IncW genetic backbone imply general trends in conjugative plasmid evolution. FEMS Microbiol. Rev. 2006;30(6):942–66. DOI: https://doi.org/10.1111/j.1574-6976.2006.00042.x</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Tulli L., Marchi S., Petracca R., et al. CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen: сollagen binding protein of Clostridium difficile. Cell. Microbiol. 2013;15(10):1674–87. DOI: https://doi.org/10.1111/cmi.12139</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Malik A., Shoombuatong W., Kim C.B., Manavalan B. GPApred: The first computational predictor for identifying proteins with LPXTG-like motif using sequence-based optimal features. Int. J. Biol. Macromol. 2023;229:529–38. DOI: https://doi.org/10.1016/j.ijbiomac.2022.12.315</mixed-citation></ref></ref-list></back></article>
